UOWF
DYN icon

University of Wisconsin Foundation’s Dyne Therapeutics DYN Stock Holding History

University of Wisconsin Foundation’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.79M Buy
484,745
+67,995
+16% +$1.17M 7.8% 9
2025
Q4 		$8.15M Sell
416,750
-101,000
-20% -$1.91M 6.85% 7
2025
Q3 		$6.55M Buy
+517,750
New +$5.91M 5.55% 8

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

University of Wisconsin Foundation's DYN Position: Q1 2026 in Review

University of Wisconsin Foundation increased its Dyne Therapeutics (DYN) stake by 16% in Q1 2026, buying an estimated $1.17M and bringing the position to 484,745 shares worth $8.79M. The position accounts for 7.8% of the portfolio, ranked #9.

University of Wisconsin Foundation first reported a position in DYN in Q3 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • University of Wisconsin Foundation held 484,745 shares of Dyne Therapeutics worth $8.79M as of Q1 2026.
  • University of Wisconsin Foundation bought 67,995 Dyne Therapeutics shares in Q1 2026, an estimated $1.17M.
  • Dyne Therapeutics made up 7.8% of University of Wisconsin Foundation's portfolio in Q1 2026, its #9 holding.
  • University of Wisconsin Foundation first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on University of Wisconsin Foundation's 13F filing for Q1 2026, filed 14 May 2026.